A detailed history of Cwa Asset Management Group, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 38,355 shares of INVA stock, worth $710,718. This represents 0.03% of its overall portfolio holdings.

Number of Shares
38,355
Previous 29,710 29.1%
Holding current value
$710,718
Previous $573,000 16.06%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025

BUY
$17.35 - $20.32 $149,990 - $175,666
8,645 Added 29.1%
38,355 $665,000
Q3 2024

Nov 01, 2024

SELL
$16.33 - $20.04 $2.44 Million - $3 Million
-149,693 Reduced 83.44%
29,710 $573,000
Q1 2024

May 13, 2024

SELL
$14.56 - $16.78 $1.08 Million - $1.25 Million
-74,356 Reduced 29.3%
179,403 $2.73 Million
Q4 2023

Feb 13, 2024

BUY
$12.32 - $16.27 $3.13 Million - $4.13 Million
253,759 New
253,759 $4.07 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.29B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Cwa Asset Management Group, LLC Portfolio

Follow Cwa Asset Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwa Asset Management Group, LLC with notifications on news.